Primary Paclitaxel Plus Gemcitabine in Patients With Stage II and III Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Paclitaxel/Gemcitabine
Sponsor: National Cancer Center, Korea